NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,359,463 | +9.9% | 247,106 | +0.8% | 0.00% | 0.0% |
| Q2 2023 | $10,338,143 | +123.8% | 245,154 | +38.4% | 0.00% | +100.0% |
| Q1 2023 | $4,620,330 | -13.0% | 177,092 | -0.7% | 0.00% | 0.0% |
| Q4 2022 | $5,309,595 | +95.4% | 178,294 | +27.6% | 0.00% | 0.0% |
| Q3 2022 | $2,717,000 | +57.1% | 139,778 | +9.6% | 0.00% | – |
| Q2 2022 | $1,730,000 | -10.8% | 127,586 | -8.6% | 0.00% | – |
| Q1 2022 | $1,939,000 | +3.4% | 139,571 | +41.7% | 0.00% | – |
| Q4 2021 | $1,875,000 | -11.3% | 98,497 | +5.0% | 0.00% | – |
| Q3 2021 | $2,115,000 | – | 93,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fairmount Funds Management LLC | 2,788,981 | $83,055,854 | 13.18% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $595,332,695 | 12.32% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $106,531 | 11.90% |
| COMMODORE CAPITAL LP | 913,621 | $27,208 | 4.10% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 302,963 | $9,022,238 | 2.58% |
| Boxer Capital, LLC | 1,210,192 | $36,039,518 | 1.90% |
| Perceptive Advisors | 2,255,007 | $67,154,108 | 1.89% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,673,214 | $49,828,313 | 0.74% |
| Avoro Capital Advisors LLC | 1,555,555 | $46,324,428 | 0.69% |
| AlphaCentric Advisors LLC | 15,500 | $461,590 | 0.46% |